<?xml version="1.0" encoding="UTF-8"?>
<p id="para1550">Overall, the nationwide prevalence of anti-HCV antibodies has drastically declined from 3·2% in 1992 to 0·43% in 2006, and is higher in northern than in southern China.
 <xref rid="bib8" ref-type="bibr">
  <sup>8</sup>
 </xref> Conversely, the reported incidence of HCV infection increased between 1997 and 2012, from 0·7 to 15·0 cases per 100 000 people, with the largest disease burden concentrated in individuals older than 35 years and rural residents.
 <xref rid="bib11" ref-type="bibr">
  <sup>11</sup>
 </xref> This change in incidence does not reflect an actual increase in incidence but improved reporting after reinforcement of the reporting system following the 2003 outbreak of severe acute respiratory syndrome coronavirus.
 <xref rid="bib12" ref-type="bibr">
  <sup>12</sup>
 </xref>
</p>
